Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Sam Altman and Arianna Huffington’s AI Health Revolution

by Team Lumida
July 9, 2024
in AI, Health and Longevity
Reading Time: 3 mins read
A A
0
Sam Altman and Arianna Huffington’s AI Health Revolution

Source: Decrypt

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  • OpenAI and Thrive Global launch Thrive AI Health to extend health spans.
  • AI health coach offers personalized advice using biometrics and lifestyle data.
  • Partnership focuses on health equity, targeting underserved populations.

What Happened?

OpenAI’s Sam Altman and Thrive Global’s Arianna Huffington announced the launch of Thrive AI Health, a new initiative aimed at revolutionizing healthcare using artificial intelligence. Thrive AI Health will develop an AI health coach offering personalized recommendations based on biometrics and lifestyle habits.

The platform will integrate Thrive’s behavior change methodology, focusing on microhabit changes. DeCarlos Love, a former Google executive, will lead as CEO. The Alice L. Walton Foundation supports this venture, and key partnerships include Stanford Medicine and the Rockefeller Neuroscience Institute.

Why It Matters?

AI in healthcare promises to address critical issues like chronic disease management and health equity. With 130 million Americans diagnosed with chronic conditions, Thrive AI Health aims to provide tailored health recommendations, potentially reducing the prevalence of chronic diseases and improving quality of life.

As Arianna Huffington emphasized, AI can democratize access to health benefits, similar to how the New Deal transformed physical infrastructure. By leveraging AI, Thrive AI Health could offer scalable, precise health interventions that human coaches cannot match.

What’s Next?

The inaugural team at Thrive AI Health is moving swiftly to customize and test the AI health coach. They plan to make the product available to Thrive Global’s employer base and expand through self-insured employers and pharmaceutical companies. As they scale, the focus will remain on maintaining robust privacy and security measures.

Partnerships with academic institutions will further aid in refining and validating the AI coach’s effectiveness. Investors and stakeholders should watch for how this platform could become integral to future health infrastructure, especially in underserved communities.

Source: Fortune Well
Tags: AI health coachArianna HuffingtonSam Altman
Previous Post

Bullish Bitcoin: Why Market Experts Predict a Major BTC Comeback

Next Post

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Recommended For You

OpenAI CFO: We’re Going Up a Vertical Wall of Demand — and May Raise Again

by Team Lumida
10 hours ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI CFO Sarah Friar says the company — now at 900 million weekly ChatGPT users — may raise additional capital beyond its record $122 billion round as a...

Read more

xAI Is Pitching Grok to Wall Street — But Bankers Aren’t Biting Yet

by Team Lumida
1 day ago
xAI Is Pitching Grok to Wall Street — But Bankers Aren’t Biting Yet

Elon Musk's xAI has recruited Apollo, Morgan Stanley, and Valor to test Grok ahead of SpaceX's IPO, but the chatbot still lags behind Anthropic's Claude for finance use...

Read more

Fanuc Hits Record High After Google Partnership Signals Physical AI’s Next Frontier

by Team Lumida
1 day ago
Google’s Bold AI Bet: Transforming Healthcare After Costly Missteps

Shares of Fanuc, the world's largest robot arm maker, surged 16% to an all-time high after announcing a partnership with Google to build AI systems for industrial robots...

Read more

Anthropic In Talks to Raise $30 Billion at a $900 Billion Valuation

by Team Lumida
2 days ago
Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic is in early discussions for what could be its largest fundraise yet, at a valuation that would make it one of the most valuable private companies in...

Read more

Hospital at Home Linked to Lower Mortality and Fewer ER Visits, JAMA Study Finds

by Team Lumida
2 days ago
dextrose hanging on stainless steel IV stand

A new JAMA Network Open study of Medicare data shows hospital-at-home programs reduce in-hospital mortality, ED visits, and ICU escalations — but adoption is concentrated in urban hospitals...

Read more

Grok Is Losing the AI Race — and SpaceX Just Rented Its Best Data Center to Anthropic

by Team Lumida
4 days ago
Tesla Shareholders Revolt: Suing Elon Musk Over Competing AI Venture

Grok downloads have collapsed 60% from their January peak, enterprise adoption is nearly flat, and SpaceX is now renting its Colossus data center to rival Anthropic for a...

Read more

South Korea Floats ‘AI Dividend’ for Citizens — Sparking a 5% Market Plunge Before Clarification

by Team Lumida
4 days ago
South Korea Floats ‘AI Dividend’ for Citizens — Sparking a 5% Market Plunge Before Clarification

A comment by Korea's top presidential policy adviser about taxing AI profits to pay citizens sent the Kospi into a 5% nosedive before he walked it back, revealing...

Read more

Microsoft Targeted a $92 Billion Return on Its $13 Billion OpenAI Bet

by Team Lumida
4 days ago
Microsoft’s AI Empire: Nadella’s Bold Moves and Billion-Dollar Bets

Court documents in the Musk v. OpenAI trial reveal Microsoft modeled a $92 billion return on its early AI investment — a target that looks conservative given OpenAI's...

Read more

8 Evidence-Based Tips for Healthy Eating, According to the NHS

by Team Lumida
4 days ago
vegetable salad

From starchy carbs to salt limits, the UK's National Health Service lays out the practical fundamentals of a balanced diet — and most adults are still getting it...

Read more

AI Dominance Has Alphabet on the Verge of Becoming the World’s Largest Company

by Team Lumida
4 days ago
Google’s Bold AI Bet: Transforming Healthcare After Costly Missteps

Alphabet's stock has surged 43% since October as its AI footprint — spanning search, chips, cloud, Gemini, and Waymo — positions it to surpass Nvidia's $5.2 trillion market...

Read more
Next Post
low angle photo of city high rise buildings during daytime

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Man on his Surface laptop at home with Christmas decorations around

AI PCs: The Future of Computing or Just Hype?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

$500 Billion Stargate AI Project Announcement Raises Funding Questions

$500 Billion Stargate AI Project Announcement Raises Funding Questions

January 23, 2025
Why Retail Investors Are Betting Big on India’s Options

Why Retail Investors Are Betting Big on India’s Options

October 14, 2024
Voters Reject 50% Property Tax Hike in Massachusetts — A Warning for Municipalities Everywhere

Voters Reject 50% Property Tax Hike in Massachusetts — A Warning for Municipalities Everywhere

April 15, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018